The SC legislature has made only tentative steps to address the growing threat of forever chemicals seeping into soil and ...

In moments of fear and uncertainty, rare individuals emerge as pillars of strength and hope. Dr. Senthil J. Rajappa is one ...

Recent regulatory actions from the FDA, including new drug application (NDA) acceptances and labeling updates, introduce new clinical considerations for oncology nurses and advanced practice providers ...

About the Role The Multiple Myeloma Nurse Coordinator will facilitate evidence based individualized, coordinated care for patients with haematological malignancies across the cancer trajectory. The ...

Besides gardening, the thing Marian enjoyed more than anything else was playing cards, especially 500 bid, at which she ...

The NDA is supported by data from the EXCALIBER-RRMM trial, which evaluated the safety and efficacy of iberdomide, an investigational cereblon E3 ligase modulator.

Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...

Ameet Patel, MD, concludes by outlining strategies to overcome operational, financial, and payer challenges in delivering advanced multiple myeloma therapies.

Ameet Patel, MD, explains how multiple myeloma treatment settings depend on safety, logistics, and patient needs.

Short Story Theatre will present an evening of six warm, wise and wonderful true stories about myriad topics, including ...

The rapid increase in demand for artificial intelligence as the technology is adopted and implemented by public- and private-sector businesses is driving the surge in data center construction ...